Home / Partnerships

Your healthcare AI infrastructure partner in Türkiye.

We build the missing parts of your Turkish operation — and run them with you.

What partners get

Everything you need to enter, integrate and scale.

RauMed runs the full market-access stack for global AI medtech firms entering Türkiye.

01

Türkiye Market Entry

End-to-end go-to-market, from positioning to first hospital deployment.

02

Regulatory Guidance

TİTCK, CE/MDR, SaMD dossiers — the regulatory plumbing.

03

Distributor Network

Four decades of distribution infrastructure — hospital procurement to the OR.

04

Pilot Hospitals

University, city and high-volume private hospitals ready for real-world validation.

05

KOL Network

Key opinion leaders across the relevant specialties.

06

Commercialization

Sales ops, training, customer success — the long game.

07

Reimbursement Strategy

SGK, private insurance, procurement-level economic modeling.

08

Localization & Support

Turkish UX, HIS/PACS/LIS integration, Tier-1 local support.

How we work together

Flexible partnership models.

Every technology enters a market differently. We structure the relationship around where you are.

01

Exclusive Türkiye Partnership

A single local partner for the entire Turkish market.

02

Distribution & Commercialization

Sales, tenders, delivery, training and local customer support.

03

Regulatory Representation

Local authorised representative, registration and compliance.

04

Clinical Pilot & Validation

Pilot hospitals, KOLs and real-world evidence generation.

05

Technology Integration

PACS/HIS integration, deployment, data and security work.

06

Joint Venture

A shared local entity for long-term market commitment.

07

Regional Expansion

Türkiye first — then the same playbook extends outward.

Who we partner with

RauMed is selective. We work with healthcare AI companies that meet at least two of three criteria:

  • Regulatory traction — FDA, CE/MDR, or clear pathway within 12 months.
  • Clinical evidence — publications, RWE, or strong investigator-led studies.
  • Strategic relevance — addresses high-volume Turkish clinical needs.

Looking the other way — are you a Turkish AI medtech founder?

RauMed also supports outbound moves — Turkish-built AI going international.